HUTT PETER BARTON 4
4 · CONCERT PHARMACEUTICALS, INC. · Filed Oct 18, 2022
Insider Transaction Report
Form 4
HUTT PETER BARTON
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2022-10-14−3,539→ 0 totalExercise: $2.88Exp: 2022-11-12→ Common Stock (3,539 underlying) - Sale
Common Stock
2022-10-14$6.09/sh−3,539$21,553→ 29,488 total - Exercise/Conversion
Common Stock
2022-10-14$2.88/sh+3,539$10,192→ 33,027 total
Footnotes (1)
- [F1]This option is fully vested.